MTEX vs. IMCC, NAII, BGXX, PIRS, EDSA, CERO, MIRA, KPRX, PPBT, and PMD
Should you be buying Mannatech stock or one of its competitors? The main competitors of Mannatech include IM Cannabis (IMCC), Natural Alternatives International (NAII), Bright Green (BGXX), Pieris Pharmaceuticals (PIRS), Edesa Biotech (EDSA), CERo Therapeutics (CERO), MIRA Pharmaceuticals (MIRA), Kiora Pharmaceuticals (KPRX), Purple Biotech (PPBT), and Psychemedics (PMD).
Mannatech (NASDAQ:MTEX) and IM Cannabis (NASDAQ:IMCC) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, community ranking, analyst recommendations, valuation, profitability, dividends, institutional ownership, media sentiment and earnings.
Mannatech received 277 more outperform votes than IM Cannabis when rated by MarketBeat users. Likewise, 74.87% of users gave Mannatech an outperform vote while only 42.86% of users gave IM Cannabis an outperform vote.
Mannatech has a net margin of -1.31% compared to IM Cannabis' net margin of -28.03%. Mannatech's return on equity of -15.37% beat IM Cannabis' return on equity.
13.0% of Mannatech shares are held by institutional investors. Comparatively, 7.7% of IM Cannabis shares are held by institutional investors. 41.5% of Mannatech shares are held by company insiders. Comparatively, 5.9% of IM Cannabis shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Mannatech has higher revenue and earnings than IM Cannabis. Mannatech is trading at a lower price-to-earnings ratio than IM Cannabis, indicating that it is currently the more affordable of the two stocks.
Mannatech has a beta of 1.18, suggesting that its share price is 18% more volatile than the S&P 500. Comparatively, IM Cannabis has a beta of 0.64, suggesting that its share price is 36% less volatile than the S&P 500.
In the previous week, Mannatech had 1 more articles in the media than IM Cannabis. MarketBeat recorded 2 mentions for Mannatech and 1 mentions for IM Cannabis. IM Cannabis' average media sentiment score of 0.44 beat Mannatech's score of 0.39 indicating that IM Cannabis is being referred to more favorably in the news media.
Summary
Mannatech beats IM Cannabis on 11 of the 15 factors compared between the two stocks.
Get Mannatech News Delivered to You Automatically
Sign up to receive the latest news and ratings for MTEX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding MTEX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Mannatech Competitors List
Related Companies and Tools